Relationship between nerve tissue and inflammatory cell infiltration in the upper airway (UA) of obstructive sleep apnoea (OSA) patients

L. Hernández, R. J. Payne, N. Naor, R. J. Kimoff (Montreal, Canada)

Source: Annual Congress 2004 - Pathogenesis of OSA
Session: Pathogenesis of OSA
Session type: Poster Discussion
Number: 2744

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Hernández, R. J. Payne, N. Naor, R. J. Kimoff (Montreal, Canada). Relationship between nerve tissue and inflammatory cell infiltration in the upper airway (UA) of obstructive sleep apnoea (OSA) patients. Eur Respir J 2004; 24: Suppl. 48, 2744

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Relationship between upper airway inflammation and systemic inflammation in obstructive sleep apnoea
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012

Nocturnal desaturation without obstructive sleep apnea (OSA) in patients with mild/moderate chronic obstructive pulmonary disease (COPD): a link with systemic inflammation (SI)?
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008


Bronchial inflammation in obstructive sleep apnea (OSA) patients
Source: Eur Respir J 2003; 22: Suppl. 45, 466s
Year: 2003

Upper airway and systemic inflammation in obstructive sleep apnoea
Source: Eur Respir J 2016; 48: 1108-1117
Year: 2016



Pathophysiology of OSA
Source: Eur Respir Mon 2010; 50: 31-50
Year: 2010


Study of inflammatory markers (C-reactive protein & tumor necrosis factor-α) in moderate to severe obstructive sleep apnea hypopnea syndrome (OSAHS) and their response to treatment with nasal continuous positive airway pressure (nCPAP)
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009


Factors influencing airway inflammation measured by exhaled NO levels in a population with obstructive sleep apnea syndrome (OSA)
Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea
Year: 2010


Association between metabolic disturbances and inflammatory markers in obstructive sleep apnea (OSAS) patients
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008


Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea
Source: Eur Respir J 2009; 33: 793-796
Year: 2009



Failure of upper airway dilator muscle activation to restore pharyngeal patency in patients with obstructive sleep apnea (OSA)
Source: Annual Congress 2008 - Pathogenesis of obstructive sleep apnoea
Year: 2008



Catecholamines and obstructive sleep apnea (OSA) severity: response to positive airway pressure (PAP) therapy
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009


Relationship between obstructive sleep apnoea syndrome (OSAS) and the levels of endothelial progenitor cells (EPC) in patients with acute stroke
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011

Natural history of idiopathic pulmonary fibrosis (IPF) associated with obstructive sleep apnea (OSA) with or without continuous positive airway pressure (CPAP)
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018


CPAP decreases plasma levels of soluble tumour necrosis factor-α receptor 1 in obstructive sleep apnoea
Source: Eur Respir J 2008; 32: 1009-1015
Year: 2008



Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008


Disturbances of respiratory muscles in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2006; 28: Suppl. 50, 418s
Year: 2006

CPAP-induced changes in upper airway (UA) dynamics assessed with magnetic phrenic nerve stimulation in awake obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2001; 18: Suppl. 33, 331s
Year: 2001

Local airway inflammation in obstructive sleep apnoea: the role of leptin
Source: Eur Respir J 2006; 28: Suppl. 50, 645s
Year: 2006

Relationship between anthropometric parameters, sleep disordered breathing and airway inflammation (AI) in obese adults affected by obstructive sleep apnea (OSA)
Source: Eur Respir J 2004; 24: Suppl. 48, 118s
Year: 2004

Why should we care about upper airway inflammation in obstructive sleep apnoea?
Source: Eur Respir J 2016; 48: 982-983
Year: 2016